Thalys Medical Technology Group Corporation (SHA:603716)
21.06
+0.15 (0.72%)
Apr 29, 2026, 3:00 PM CST
SHA:603716 Market Cap
SHA:603716 has a market cap or net worth of 4.48 billion as of April 29, 2026. Its market cap has increased by 130.85% in one year.
Market Cap
4.48B
Enterprise Value
4.68B
Revenue
971.32M
Ranking
n/a
PE Ratio
n/a
Stock Price
21.06
Market Cap Chart
Since October 31, 2016, SHA:603716's market cap has increased from 1.97B to 4.48B, an increase of 126.80%. That is a compound annual growth rate of 9.01%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SMO ClinPlus CO.,LTD. | 4.51B |
| Guangdong Hybribio Biotech | 3.83B |
| Shanghai Labway Clinical Laboratory | 3.78B |
| Medicalsystem Biotechnology | 3.71B |
| Berry Genomics Co.,Ltd | 3.45B |
| Cowealth Medical China | 6.19B |
| Maccura Biotechnology Co.Ltd | 6.31B |
| Chemclin Diagnostics | 2.86B |